Drug shows potential for people with mild Alzheimer’s disease

Having trouble viewing this message? You may view it as a web page. You may also view e-news archives.
To prevent mailbox filters from deleting your Alzheimer's Association email communications, please add alzheimers_enews@alz.org to your address book.


	Forward to a Friend

October 10, 2012

Drug shows potential for people with mild Alzheimer's disease

Solanezumab, an experimental Alzheimer's drug, did not slow mental decline in each of two phase 3 clinical trials, but a positive effect was seen when data from both studies was combined. Drug maker Eli Lilly & Co. said that combining the results of the two trials showed a 34 percent slowing of mental decline for people with mild Alzheimer's who took solanezumab compared to those taking a placebo. While more research is needed, the results suggest that a therapy targeting beta amyloid can have a beneficial effect on cognitive abilities in people with Alzheimer's.
Read the article >>

Three drugs selected for DIAN TU clinical trial

Scientists at the Dominantly Inherited Alzheimer's Network Trials Unit (DIAN TU) have selected three drugs to be evaluated in the first phase of this innovative international clinical trial. The drugs each target beta amyloid — the main ingredient in the brain plaques found in people with Alzheimer's — in a different way. The Alzheimer's Association provided $4.2 million in funding for DIAN to build the essential infrastructure for its Trials Unit.
Read the article >>

An attorney prosecutes her toughest foe: Alzheimer's

After being diagnosed with younger-onset Alzheimer's, Seattle attorney Myriam Marquez has dedicated her life to spreading awareness and finding a cure for the disease. Among her many activities fighting Alzheimer's, Marquez is an Alzheimer's Association Early-Stage Advisor.
Read the article >>
Learn more about living with younger-onset Alzheimer's >>

Caregiver resource links

Alzheimer's Behaviors >>

Caregiver Stress Check >>

Comfort Zone® >>

Coping with Alzheimer's >>

Daily Care >>

Find a Clinical Trial >>

Long-Distance Caregiving >>

Music, Art and Other Therapies >>

Support Groups >>

Planning Ahead >>

Stop by our brain gym

Exercise your brain and test
your skills.

Solve today's puzzle >>

What is Alzheimer's Disease | Know the 10 Signs of Alzheimer's | Brain Tour

The Alzheimer's Association is the leading voluntary health organization in Alzheimer's care, support and research. Our mission is to eliminate Alzheimer's disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health.

To change your email preferences click here.